Reprise Biomedical Overview

  • Year Founded
  • 2019

Year Founded

  • Status
  • Private

  • Employees
  • 50

Employees

  • Latest Deal Type
  • Later Stage VC

  • Latest Deal Amount
  • $14.2M

  • Investors
  • 2

Reprise Biomedical General Information

Description

Operator of a biological medical device company intended to develop and commercialize biologic medical devices. The company offers biologic wound matrices and soft tissue reinforcement products manufactured using proprietary perfusion decellularization technology, enabling healthcare providers to manage wounds and reinforce soft tissue.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 17400 Medina Road
  • Suite 100
  • Plymouth, MN 55447
  • United States
+1 (763)
Primary Industry
Medical Supplies
Other Industries
Biotechnology
Surgical Devices
Vertical(s)
Corporate Office
  • 17400 Medina Road
  • Suite 100
  • Plymouth, MN 55447
  • United States
+1 (763)

Reprise Biomedical Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Reprise Biomedical Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
7. Later Stage VC 01-Jul-2026 $14.2M Completed Generating Revenue
6. Early Stage VC 13-Dec-2023 Completed Generating Revenue
5. Early Stage VC 25-Jan-2023 Completed Generating Revenue
4. Early Stage VC 30-Mar-2021 Completed Generating Revenue
3. Debt - PPP 06-Apr-2020 Completed Generating Revenue
2. Early Stage VC 12-Jul-2019 $12.5M $12.5M Completed Startup
1. Spin-Off 01-Jan-2019 Completed Startup
To view Reprise Biomedical’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Reprise Biomedical Patents

Reprise Biomedical Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20240424276-A1 Wound management assemblies, kits, and methods Pending 21-Jun-2023
US-20250049989-A1 Tunnel filler device and methods of use Pending 31-May-2022
WO-2023235737-A1 Tunnel filler device and methods of use Inactive 31-May-2022
US-11998662-B1 Biologic matrix for a wound site and related methods Active 09-Jun-2021
US-12115284-B1 Biologic matrix for a wound site and related methods Active 09-Jun-2021 A61L27/56
To view Reprise Biomedical’s complete patent history, request access »

Reprise Biomedical Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Reprise Biomedical Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds
John Lilly Strategic Insights Corporation Minority
Lateral Capital Management Venture Capital Minority
To view Reprise Biomedical’s complete investors history, request access »

Reprise Biomedical FAQs

  • When was Reprise Biomedical founded?

    Reprise Biomedical was founded in 2019.

  • Where is Reprise Biomedical headquartered?

    Reprise Biomedical is headquartered in Plymouth, MN.

  • What is the size of Reprise Biomedical?

    Reprise Biomedical has 50 total employees.

  • What industry is Reprise Biomedical in?

    Reprise Biomedical’s primary industry is Medical Supplies.

  • Is Reprise Biomedical a private or public company?

    Reprise Biomedical is a Private company.

  • What is Reprise Biomedical’s current revenue?

    The current revenue for Reprise Biomedical is .

  • How much funding has Reprise Biomedical raised over time?

    Reprise Biomedical has raised $54.9M.

  • Who are Reprise Biomedical’s investors?

    John Lilly Strategic Insights and Lateral Capital Management have invested in Reprise Biomedical.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process